British inhaled drug delivery company specializing in treatments for respiratory diseases like asthma and COPD — acquired by Philip Morris International in 2021 in a controversial move that raised ethical questions about a tobacco company owning a respiratory medicine business.
Represents the most striking corporate ethics conflict of recent years — a company that caused respiratory disease (Philip Morris) acquiring a company that treats it (Vectura) created a public outcry about corporate ethics in health.
Discussing
Ask anything about Vectura — their ideas, influences, contradictions, legacy.
Sign in to start a conversation.